A Study to Investigate Efficacy and Safety of Different Dose Regimen of Oral Cabazitaxel Tablet in Adult Participants with Prostate Cancer
Clinical trial NCT06890832 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06890832
- Sponsor
- Jina Pharmaceuticals Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2026-12-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.